Professor Andrew Spencer and his team have established a large prospective registry of newly-diagnosed patients with myeloma, plasmacytoma, plasma cell leukaemia and MGUS. The Myeloma and Related Diseases Registry (MRDR) is providing rich real world data to help inform clinical practice. In this podcast, we talk to Professor Spencer about how the findings from the ...
Podcast: Real world data on practice trends, outcomes and survival in multiple myeloma
Sponsored by Janssen-Cilag Pty Ltd
29 Nov 2018